查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1541645

2024-2032 年吸入麻醉市场报告（按产品（地氟烷、七氟烷、异氟烷等）、应用（诱导、维持）、最终用户（医院、门诊手术中心等）和地区

Inhalation Anesthesia Market Report by Product (Desflurane, Sevoflurane, Isoflurane, and Others), Application (Induction, Maintenance), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球吸入麻醉市场规模达16.0亿美元。慢性疾病的盛行率日益上升，製药公司、医疗器材製造商和医疗机构之间的合作，以及政府和私人医疗保健提供者对最先进设备的投资不断增加是推动市场的一些主要因素。

吸入麻醉市场分析：

市场成长与规模：市场正在稳步成长，这可归因于全球外科手术的增加和医疗保健基础设施的进步。此外，各种外科手术对麻醉的需求不断增长正在推动吸入麻醉市场的成长。

主要市场驱动因素：慢性病盛行率不断上升、老年人口不断增加以及人们对手术中吸入麻醉益处的认识不断提高是推动市场的一些关键因素。此外，麻醉输送系统的技术进步和新麻醉剂的推出正在刺激市场成长。

主要市场趋势：吸入麻醉 产业趋势包括，由于吸入麻醉具有起效快、给药方便、恢復快速等优点，门诊手术中心越来越多地采用吸入麻醉。此外，人们正在转向开发环保麻醉剂和输送系统，以尽量减少对环境的影响。

地理趋势：北美因其完善的医疗基础设施、高手术率以及强劲的研发 (R&D) 活动而引领市场。然而，在医疗支出增加、医疗设施改善和庞大患者群体的推动下，亚太地区正在成为一个快速成长的市场。

竞争格局：市场的特征是主要参与者之间竞争激烈。他们专注于策略性倡议，例如併购 (M&A)、产品发布和合作，以加强其市场地位并扩大其产品组合。

挑战与机会：虽然市场面临挑战，例如管理麻醉药物和设备的审批和商业化的严格监管框架，但由于对微创（MI）手术和正在进行的研究活动的需求不断增加，新兴市场也遇到了机会新型麻醉剂及给药方法。

吸入麻醉市场趋势：

麻醉剂和输送系统的不断进步

製药公司和医疗设备製造商正在大力投资研发，以创造更有效、更安全的麻醉气体和蒸气。这些创新旨在透过降低不良反应的风险和改善整体麻醉体验来提高患者的治疗效果。正在开发具有改进的药物动力学特征的新型药物，能够更快地诱导和苏醒，从而缩短患者在手术室的时间。此外，复杂的输送系统（包括精确的蒸发器和监控技术）的开发可确保麻醉剂的准确给药和滴定，最大限度地减少剂量过量或不足的可能性。这些进步不仅有助于更好的患者护理，还吸引医疗保健提供者采用这些现代解决方案，从而促进吸入麻醉市场的成长。

手术数量和患者数量不断增加

人口成长通常伴随着人口老化，与外科手术需求的增加直接相关。由于与年龄相关的疾病，例如心血管疾病、关节置换和癌症治疗，老年人口往往需要更多的医疗干预。因此，骨科、心臟病学、肿瘤学和一般外科等外科专业的需求增加。由于起效快且镇静深度可控，吸入麻醉被证明是这些手术的首选。它在确保患者失去知觉和维持其生理稳定性之间提供了平衡。此外，医学知识和技术的扩展拓宽了可行手术介入的范围。微创手术、机器人辅助手术和其他创新技术的出现，使得介入措施更加安全快速。

扩建门诊手术中心

ASC 具有许多优势，例如成本效益、缩短患者住院时间以及降低医院获得性感染的风险。吸入麻醉起效快、恢復快，非常符合 ASC 的要求。在 ASC 接受手术的患者通常更喜欢吸入麻醉，因为这样可以让他们更快恢復日常活动。此外，吸入麻醉能够最大限度地减少术后噁心和呕吐，这在门诊环境中特别有价值。随着ASC数量的增长以满足门诊手术不断增长的需求，吸入麻醉的需求预计将大幅增加。这一趋势也鼓励製造商开发更便携、更用户友好的麻醉输送系统，以满足 ASC 的独特需求。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球吸入麻醉市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 地氟烷
    • 市场趋势
    • 市场预测
  • 七氟醚
    • 市场趋势
    • 市场预测
  • 异氟烷
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按应用

  • 就职
    • 市场趋势
    • 市场预测
  • 维护
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场趋势
    • 市场预测
  • 门诊手术中心
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbvie Inc.
    • Baxter International Inc.
    • Fresenius SE & Co. KGaA
    • Halocarbon Products Corporation
    • Hikma Pharmaceuticals PLC
    • Lunan Pharmaceutical Group Co. Ltd
    • Merck KGaA
    • Piramal Enterprises Ltd.
    • Troikaa Pharmaceuticals Ltd
Product Code: SR112024A3998

The global inhalation anesthesia market size reached US$ 1.60 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.16 Billion by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032. The increasing prevalence of chronic medical disorders, collaborations between pharmaceutical companies, medical device manufacturers, and healthcare institutions, and the rising investments by governments and private healthcare providers in state-of-the-art equipment are some of the major factors propelling the market.

Inhalation Anesthesia Market Analysis:

Market Growth and Size: The market is witnessing steady growth, which can be attributed to increasing surgical procedures worldwide and advancements in healthcare infrastructure. In addition, the rising demand for anesthesia in various surgical procedures is propelling the inhalation anesthesia market growth.

Major Market Drivers: The growing prevalence of chronic diseases, expanding geriatric population, and rising awareness about the benefits of inhalation anesthesia in surgeries are some of the key factors driving the market. Additionally, technological advancements in anesthesia delivery systems and the introduction of new anesthetic agents are stimulating the market growth.

Key Market Trends: Inhalation anesthesia Industry trends include the increasing adoption of inhalation anesthesia in ambulatory surgical centers due to its advantages, such as rapid onset, easy administration, and faster recovery. Moreover, there is a shift towards the development of eco-friendly anesthetic agents and delivery systems to minimize environmental impact.

Geographical Trends: North America leads the market owing to its well-established healthcare infrastructure, high surgical procedure rates, and robust research and development (R&D) activities. However, Asia Pacific is emerging as a fast-growing market, driven by rising healthcare expenditures, improving healthcare facilities, and a large patient pool.

Competitive Landscape: The market is characterized by intense competition among key players. They are focusing on strategic initiatives, such as mergers and acquisitions (M&A), product launches, and collaborations, to strengthen their market position and expand their product portfolios.

Challenges and Opportunities: While the market faces challenges, such as stringent regulatory framework governing the approval and commercialization of anesthesia drugs and devices, it also encounters opportunities in in emerging markets due to the increasing demand for minimally invasive (MI) surgeries and ongoing research activities on novel anesthetic agents and delivery methods.

Inhalation Anesthesia Market Trends:

Continual Advancements in Anesthetic Agents and Delivery Systems

Pharmaceutical companies and medical device manufacturers are heavily investing in research and development to create more effective and safer anesthetic gases and vapors. These innovations aim to enhance patient outcomes by reducing the risk of adverse effects and improving the overall anesthesia experience. Newer agents are being developed with improved pharmacokinetic profiles, enabling faster induction and emergence from anesthesia, thus shortening the time patients spend in the operating room. Furthermore, the development of sophisticated delivery systems, including precise vaporizers and monitoring technologies, ensures accurate administration and titration of anesthetic agents, minimizing the chances of over or under dosing. These advancements not only contribute to better patient care but also attract healthcare providers to adopt these modern solutions, thus catalyzing the growth of the inhalation anesthesia market.

Rising Surgical Procedures and Patient Volume

Population growth, often accompanied by an aging demographic, directly correlates with a heightened demand for surgical procedures. The elderly population tends to require more medical interventions due to age-related ailments, such as cardiovascular diseases, joint replacements, and cancer treatments. Consequently, surgical specialties such as orthopedics, cardiology, oncology, and general surgery have seen a rise in demand. Inhalation anesthesia proves to be a preferred option for these procedures due to its rapid onset and controllable depth of sedation. It offers a balance between ensuring patient's unconsciousness and maintaining their physiological stability. Furthermore, the expansion of medical knowledge and technology has broadened the spectrum of feasible surgical interventions. Minimally invasive procedures, robotics-assisted surgeries, and other innovative techniques have emerged, allowing for safer and quicker interventions.

Expansion of Ambulatory Surgical Centers

ASCs offer numerous advantages, such as cost-effectiveness, shorter patient stays, and reduced risk of hospital-acquired infections. Inhalation anesthesia aligns well with the requirements of ASCs due to its rapid onset and quick recovery profile. Patients undergoing procedures at ASCs often prefer inhalation anesthesia as it allows them to return to their daily activities more swiftly. Moreover, inhalation anesthesia's ability to minimize post-operative nausea and vomiting is particularly valuable in an outpatient setting. As the number of ASCs grows to accommodate the increasing demand for outpatient surgeries, the demand for inhalation anesthesia is expected to witness a significant rise. This trend also encourages manufacturers to develop more portable and user-friendly anesthesia delivery systems tailored to the unique needs of ASCs.

Inhalation Anesthesia Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global inhalation anesthesia market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Desflurane

Sevoflurane

Isoflurane

Others

Sevoflurane dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes desflurane, sevoflurane, isoflurane, and others. According to the report, sevoflurane represented the largest segment.

Sevoflurane's popularity is largely due to its favorable pharmacokinetic profile. With its rapid induction and emergence characteristics, sevoflurane enables anesthesiologists to guide patients swiftly and smoothly into and out of anesthesia. This not only enhances operational efficiency in medical settings but also ensures that patients experience minimal delay in the start and conclusion of surgical procedures. Moreover, sevoflurane's low blood-gas solubility allows for rapid equilibration between the lungs and the bloodstream, translating into quicker adjustments in the depth of anesthesia and the potential for faster recoveries. Sevoflurane's reduced likelihood of causing organ toxicity or compromising vital functions offers a degree of reassurance to both medical professionals and patients. This safety aspect has been pivotal in cementing sevoflurane's role as a cornerstone of inhalation anesthesia practice, particularly in paediatric and geriatric populations where safety is of paramount concern.

Breakup by Application:

Induction

Maintenance

Maintenance dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes induction and maintenance. According to the report, maintenance represented the largest segment.

The prominence of the maintenance phase is attributed to its role in ensuring patient comfort, surgical precision, and optimal outcomes. Once the patient is induced into anesthesia and the initial surgical incisions are made, maintaining the appropriate anesthetic depth becomes paramount. Anesthesia providers carefully titrate inhalation anesthetic agents to balance the patient's need for complete insensitivity to pain while avoiding over-sedation, which could lead to complications or lengthened recovery times. This dynamic balance requires continuous monitoring and adjustment throughout the procedure, highlighting the importance of skilled anesthesiologists. Moreover, the maintenance phase is directly linked to surgical efficacy and precision. Surgeons rely on patients being adequately anesthetized and immobilized to perform delicate procedures with accuracy. Any fluctuation in the anesthesia depth during the maintenance phase could lead to patient movement or awareness, potentially compromising the surgery's success.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.

Hospitals offer a diverse range of medical services, encompassing routine surgeries, emergency interventions, and specialized procedures across various medical specialties. The sheer volume and variety of surgical interventions conducted in hospitals create a substantial demand for anesthesia services, and inhalation anesthesia, with its ability to provide rapid induction and adjustable sedation levels, aligns seamlessly with the dynamic environment of hospital operating rooms. Additionally, hospitals provide a comprehensive infrastructure for anesthesia administration and patient care. They possess well-equipped operating suites, sophisticated monitoring systems, and experienced anesthesia teams capable of managing a wide spectrum of cases. This robust setup allows hospitals to efficiently manage the complexities associated with different surgeries, including those requiring inhalation anesthesia. Furthermore, the presence of specialized units within hospitals, such as pediatric and cardiac surgery departments, highlights the versatility of inhalation anesthesia across diverse patient populations and procedural requirements.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest inhalation anesthesia market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is characterized by its emphasis on medical advancements and innovation. The presence of renowned research institutions, academic medical centers, and cutting-edge pharmaceutical companies fosters an environment conducive to the development of new anesthetic agents, delivery methods, and monitoring technologies. This commitment to innovation not only enhances patient care but also attracts healthcare professionals to adopt state-of-the-art anesthesia practices, including inhalation anesthesia techniques. The region's regulatory landscape and adherence to stringent safety standards further contribute to its dominance. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) play a pivotal role in ensuring the safety and efficacy of anesthesia agents and equipment. This rigorous oversight augments the confidence of healthcare providers and patients in the use of inhalation anesthesia, solidifying North America's position as a leader in the field. Also, North America's focus on medical education and training ensures that anesthesia providers are well-equipped to administer inhalation anesthesia safely and efficiently.

Competitive Landscape:

Pharmaceutical and medical device companies are heavily investing in research and development to create advanced anesthetic agents, delivery systems, and monitoring technologies. Moroever, companies are frequently introducing new inhalation anesthesia products and equipment to cater to the evolving needs of healthcare providers and patients. These products often incorporate the latest technological advancements, such as more precise vaporizers, integrated monitoring systems, and user-friendly interfaces. Additionally, leading players are focusing on developing innovative technologies that enhance the administration and monitoring of inhalation anesthesia. This includes the integration of electronic medical records (EMR) systems, real-time data analysis, and remote monitoring capabilities to ensure optimal patient care and safety. Additionally, numerous companies are providing training and educational programs to healthcare professionals, including anesthesiologists, nurse anaesthetists, and operating room staff. These programs help ensure that healthcare providers are well-versed in the latest techniques, technologies, and safety measures related to inhalation anesthesia.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbvie Inc.

Baxter International Inc.

Fresenius SE & Co. KGaA

Halocarbon Products Corporation

Hikma Pharmaceuticals PLC

Lunan Pharmaceutical Group Co. Ltd

Merck KGaA

Piramal Enterprises Ltd.

Troikaa Pharmaceuticals Ltd.

Recent Developments:

In May 2023, Piramal Enterprises Ltd collaborated with plus therapeutics to meet increase in investigational drug demand for ongoing and planned clinical trials.

In April 2023, Baxter International Inc. launched Zosyn Premix. It is indicated for the treatment of multiple infections caused by susceptible bacteria.

In December 2021, Hikma Pharmaceuticals PLC launched Bupivacaine HCl Injection. Bupivacaine HCl Injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures.

Key Questions Answered in This Report

  • 1. What was the size of the global inhalation anesthesia market in 2023?
  • 2. What is the expected growth rate of the global inhalation anesthesia market during 2024-2032?
  • 3. What are the key factors driving the global inhalation anesthesia market?
  • 4. What has been the impact of COVID-19 on the global inhalation anesthesia market?
  • 5. What is the breakup of the global inhalation anesthesia market based on the product?
  • 6. What is the breakup of the global inhalation anesthesia market based on the application?
  • 7. What is the breakup of the global inhalation anesthesia market based on the end user?
  • 8. What are the key regions in the global inhalation anesthesia market?
  • 9. Who are the key players/companies in the global inhalation anesthesia market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Inhalation Anesthesia Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Desflurane
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Sevoflurane
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Isoflurane
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Induction
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Maintenance
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbvie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baxter International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Fresenius SE & Co. KGaA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Halocarbon Products Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Hikma Pharmaceuticals PLC
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Lunan Pharmaceutical Group Co. Ltd
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Merck KGaA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Piramal Enterprises Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Troikaa Pharmaceuticals Ltd
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Inhalation Anesthesia Market: Major Drivers and Challenges
  • Figure 2: Global: Inhalation Anesthesia Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Inhalation Anesthesia Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Inhalation Anesthesia Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Inhalation Anesthesia Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Inhalation Anesthesia Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Inhalation Anesthesia Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Inhalation Anesthesia (Desflurane) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Inhalation Anesthesia (Desflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Inhalation Anesthesia (Sevoflurane) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Inhalation Anesthesia (Sevoflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Inhalation Anesthesia (Isoflurane) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Inhalation Anesthesia (Isoflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Inhalation Anesthesia (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Inhalation Anesthesia (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Inhalation Anesthesia (Induction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Inhalation Anesthesia (Induction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Inhalation Anesthesia (Maintenance) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Inhalation Anesthesia (Maintenance) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Inhalation Anesthesia (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Inhalation Anesthesia (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Inhalation Anesthesia (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Inhalation Anesthesia (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Inhalation Anesthesia Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Inhalation Anesthesia Industry: SWOT Analysis
  • Figure 76: Global: Inhalation Anesthesia Industry: Value Chain Analysis
  • Figure 77: Global: Inhalation Anesthesia Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Inhalation Anesthesia Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Inhalation Anesthesia Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Inhalation Anesthesia Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Inhalation Anesthesia Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Inhalation Anesthesia Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Inhalation Anesthesia Market: Competitive Structure
  • Table 7: Global: Inhalation Anesthesia Market: Key Players